CAS No.:2062-78-4
Name: Pimozide
Details Introduction
TOXICITY DATA with REFERENCE:
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| dog | LD50 | intravenous | 32mg/kg (32mg/kg) | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 5, Pg. 106, 1974. | |
| dog | LD50 | oral | 40mg/kg (40mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD |
Arzneimittel-Forschung. Drug Research. Vol. 18, Pg. 261, 1968. |
| guinea pig | LD50 | oral | 189mg/kg (189mg/kg) | BEHAVIORAL: TREMOR BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD |
Arzneimittel-Forschung. Drug Research. Vol. 18, Pg. 261, 1968. |
| man | TDLo | oral | 7714ug/kg/15W (7.714mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: FLUID INTAKE KIDNEY, URETER, AND BLADDER: URINE VOLUME INCREASED |
Journal of Clinical Pyschopharmacology. Vol. 12, Pg. 140, 1992. |
| mouse | LD50 | intraperitoneal | 1070mg/kg (1070mg/kg) | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 5, Pg. 106, 1974. | |
| mouse | LD50 | intravenous | 14mg/kg (14mg/kg) | "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972Vol. -, Pg. 288, 1972. | |
| mouse | LD50 | oral | 228mg/kg (228mg/kg) | BEHAVIORAL: ATAXIA | Collection of Czechoslovak Chemical Communications. Vol. 42, Pg. 1179, 1977. |
| mouse | LD50 | subcutaneous | > 16gm/kg (16000mg/kg) | BRAIN AND COVERINGS: RECORDINGS FROM SPECIFIC AREAS OF CNS SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE |
Kiso to Rinsho. Clinical Report. Vol. 6, Pg. 629, 1972. |
| rabbit | LD50 | intravenous | 22mg/kg (22mg/kg) | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 5, Pg. 106, 1974. | |
| rabbit | LD50 | oral | 40mg/kg (40mg/kg) | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 5, Pg. 106, 1974. | |
| rat | LD50 | intraperitoneal | 350mg/kg (350mg/kg) | Drugs in Japan Vol. 6, Pg. 639, 1982. | |
| rat | LD50 | intravenous | 90mg/kg (90mg/kg) | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 5, Pg. 106, 1974. | |
| rat | LD50 | oral | 1100mg/kg (1100mg/kg) | Drugs in Japan Vol. 6, Pg. 639, 1982. | |
| rat | LD50 | subcutaneous | > 11gm/kg (11000mg/kg) | BRAIN AND COVERINGS: RECORDINGS FROM SPECIFIC AREAS OF CNS SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE |
Kiso to Rinsho. Clinical Report. Vol. 6, Pg. 629, 1972. |
Consensus Reports:
SAFETY PROFILE:
Poison by ingestion, intravenous, and intraperitoneal routes. An experimental teratogen. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of NOx and F−.
Hazard Codes
Xn
Risk Statements 22
R22:Harmful if swallowed.
Safety Statements 36
S36:Wear suitable protective clothing.
RIDADR 3249
WGK Germany 3
RTECS DE1750000
HazardClass 6.1(b)
PackingGroup III
Standards and Recommendations:
Analytical Methods:
Related Searches
Other Product
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (4S,6R)-6-{2-[(2-hydroxy-ethyl)-(4-methoxy-benzenesulfonyl)-amino]-ethoxy}-4-isopropyl-5,6-dihydro-4H-pyran-2-carboxylic acid allyl ester
- [1,4'-Bipiperidine]-1'-carboxylic acid, 4-(1H-indol-7-yl)-, ethyl ester
- 1,3,5-Tris(4-acetamidophenyl)penta-1,5-dione
- 1,5-Bis(3-aminophenyl)-3-(4-N,N-di-methylaminophenyl)penta-1,5-dione
- 1,5-Bis(4-acetamidophenyl)-3-phenylpenta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-(4-acetamido-phenyl)penta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-phenylpenta-1,5-dione


